Stanley Perlman
Affiliations: | University of Iowa, Iowa City, IA |
Area:
Microbiology BiologyGoogle:
"Stanley Perlman"Children
Sign in to add trainee| Gregory F. Wu | grad student | 2001 | University of Iowa |
| Jodie S. Haring | grad student | 2002 | University of Iowa |
| Taeg S. Kim | grad student | 2004 | University of Iowa |
| Evelena P. Ontiveros | grad student | 2004 | University of Iowa |
| Ajai A. Dandekar | grad student | 2005 | University of Iowa |
| Daniela Anghelina | grad student | 2007 | University of Iowa |
| Noah S. Butler | grad student | 2007 | University of Iowa |
| Steven P. Templeton | grad student | 2007 | University of Iowa |
| Haixia Zhou | grad student | 2007 | University of Iowa |
| Jason M. Netland | grad student | 2009 | University of Iowa |
| Kathryn R. Trandem | grad student | 2012 | University of Iowa |
| Jonathan A. Trujillo | grad student | 2014 | University of Iowa |
| Anthony R Fehr | post-doc | 2012-2018 | University of Iowa Carver College of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fumagalli V, Ravà M, Marotta D, et al. (2024) Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination. Nature Immunology |
| Shi J, Zheng J, Zhang X, et al. (2024) A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodies. Jci Insight. 9 |
| Li K, Verma A, Li P, et al. (2024) Adaptation of SARS-CoV-2 to ACE2 mice reveals new spike residues that drive mouse infection. Journal of Virology. e0151023 |
| Li P, Kim Y, Dampalla CS, et al. (2023) Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment. Mbio. e0287823 |
| Pan R, Meyerholz DK, Perlman S. (2023) Cells that survive acute murine SARS-CoV-2 infection are detected nearly exclusively in the respiratory tract. The Journal of Clinical Investigation. 133 |
| Wong L-YR, Odle A, Luhmann E, et al. (2023) Contrasting roles of MERS-CoV and SARS-CoV-2 internal proteins in pathogenesis in mice. Mbio. e0247623 |
| Fumagalli V, Di Lucia P, Ravà M, et al. (2023) Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses. Embo Molecular Medicine. e17580 |
| Zheng J, Channappanavar R, Perlman S. (2023) Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S. Star Protocols. 4: 102171 |
| Honrubia JM, Gutierrez-Álvarez J, Sanz-Bravo A, et al. (2023) SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators. Mbio. e0313622 |
| Verma AK, Zheng J, Meyerholz DK, et al. (2022) SARS-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways. Jci Insight |